Global Bio-Implants Market worth $134.4 Billion by 2019

Global Bio implants market report brings into light key market dynamics of the sector. It reveals the nature of demand for the firm’s product to know if the demand for the product is constant or seasonal. The info covered helps businesses know how patents, licensing agreements and other legal restrictions affect the manufacture and sale of the firm’s products. Implantable Devices industry is anticipated to witness higher growth during the forecast period due to growing demand at the end user level. Moreover, strategic model around the growth objective is designed by analysts, with a detailed route-to-market analysis, competencies to be leveraged and developed, as well as any potential pitfalls.

Global Bio-Implants Market is expected to reach USD 308,837.20 million by 2025 from USD 186,162.16 million in 2018, at a CAGR of 7.5% in the forecast period 2018 to 2025.

The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Get Free Report Sample @

Major Players: Global Bio-Implants Market

Some of the major players operating in this market are-Abbott Laboratories, Medtronic, Boston Scientific Corporation, Bio-Rad Laboratories, Inc., Somnomed Limited, Johnson & Johnson Services, Inc., Edwards Lifesciences Corporation, F. Hoffmann-La Roche AG, C.R. Bard, Inc., Mimedx Group, Inc. and Biotronik Se & Co.Kg among others.

Segmentation: Global Bio-Implants Market

Product Type

Orthopedics & Trauma,

Pacing Devices,

Stents & Related Implants,

Spinal Implants,

Ophthalmic Implants,

Structural Cardiac Implants,

Dental Implants,

Neurostimulators Implants,

Prosthetic Implants







Biomaterial Metal,




Acrylic Hydrogel

Mode Of Administration






Ambulatory Surgical Centers


North America,



South America,

Middle East and Africa

Read Full TOC with Tables at @

Drivers: Global Bio-Implants Market

The major factors driving the growth of this market are rising number of aging and geriatric population, changing lifestyle problems, rising incidence of chronic diseases, increasing awareness about cosmetic implants, technological advancement in implants, rising demand for non-surgical bio-implants are the factors which is driving the growth of the market.


There has been gradual demographic transition from patterns of high fertility and mortality to low fertility and delayed mortality rates. As a result of such demographic transitions, the shape of global age distribution is changing. Increase in hypertension, temperature, etc. causes demand for vital sign monitoring devices. High blood pressure can lead to heart diseases, kidney diseases, and heart stroke and also cause death at times.

According to the Centres for Disease Control and Prevention (CDC), about 70.0% of US adults of age 65 or older have high blood pressure and only 50.0% of them have it under control (less than 140/90 mmHg). The high blood pressure causes several diseases like coronary artery disease, dementia, kidney failure, kidney artery aneurysm which is affecting the geriatric population. The diseases leads to disability, low quality of life, increase in health and long term care costs.

Speak to Our Authors:-

Below are some spinal disorders data listed:

According to National Spinal Cord Injury Statistical Center (NSCSC), Out of the 314 million people in US almost 54.0% of the population is suffering from spinal cord injury (SCI).

Around 17,000 new cases of the SCI are registered per year in US.

About 4.0% to 6.0% of the U.S. population is diagnosed with spondylolysis and spondylolisthesis.

The rising cases of chronic diseases are increasing the implant surgeries to be performed for their treatment which has then grown the number of implants to be manufactured and ultimately it is boosting the market of the bio-implants.


Advancements in technology in the bio-implants market have seen a drastic change over the years. A bio-implant is an implant that comprises of a biological component which is inserted inside the human body. As the technology gets advanced day by day, various new technologies have evolved in the market. For example, 3D printed bio-implants; these are the biological implants which are developed using the biological materials which include cells, protein using bio printing. These implants are called as organ printing because similar autologous cells are used for the reduced rejection by the body and also for reducing the waiting time for the replacement organ.


Non-surgical treatment for the various implant surgeries is found to be effective without any lesions made in the body. The need for the non-surgical treatment for the wide range of problems such as dental ailments, soft tissue related problems has increased the market in the last few years. For instance, the non-invasive dental implants are used.

Inquiry before Buying @

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research

Tel: +1-888-387-2818



Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *